Nonalcoholic steatohepatitis (NASH) is liver inflammation caused by a buildup of fat in the liver.
Wake Research Associates is enrolling volunteers in a study testing the effectiveness, and safety of an investigational medication for individuals with NASH and associated bridging fibrosis.
Qualified Participants Must:
Be age 18-70
Have a history of NASH and bridging fibrosis confirmed by a liver biopsy in the last 6 months
*Other conditions may apply
Qualified Participants May Receive:
- Study-related medication at no cost
- Study-related medical exams at no cost
- Compensation of up to $1875 for time and travel